Funding news
0x logo

0x Raises Impressive Round in Series C Funding for Crypto Financial Products Platform

Recently funded · Series cCryptocurrency

Get the full 0x company profile

Access contacts, investors, buying signals & more

Open in Dashboard

We are thrilled to announce that 0x has successfully raised a significant funding round aimed at enhancing our mission to empower developers in building advanced financial products on decentralized infrastructure. With a robust backing amounting to $109 million raised to date, 0x has solidified its position as a leader in the crypto finance space. Our revolutionary tools and APIs have enabled developers to facilitate over 52 million transactions, managing a staggering $125 billion in volume, as users engage seamlessly with top-tier applications like Coinbase Wallet, Matcha, and Metamask. This influx of capital will allow us to accelerate enhancements to our technology stack, expand our developer resources, and widen the adoption of our decentralized exchange aggregator, Matcha. As a company founded in 2017 and renowned for our significant contributions to the Ethereum ecosystem, including the introduction of the ERC721 NFT token standard, we are committed to transforming the way financial products are built and traded online. With support from leading investors such as Pantera Capital, Greylock, Coinbase, and Jump, we are excited to take the next step in our journey. This funding will help us innovate faster, improve user experiences, and ultimately democratize access to finance through the power of decentralized technologies. Stay tuned as we unveil new products and features designed to meet the evolving needs of developers and users alike!

Other recently funded companies

View all

Other recent Series c rounds

Companies that recently closed a Series c round.

#CompanyAmount
1
Pluang logo

Pluang

Indonesia

$10.0M
2
Rapido logo

Rapido

India

$18.0M
3
Butterfly Medical logo

Butterfly Medical

Israel

$21.0M
4
Yabie logo

Yabie

Sweden

$26.2M
5
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

United States

$50.5M